P153 An integrated analysis of zoledronic acid (ZA) for prevention of aromatase inhibitor associated bone loss (AIBL) in postmenopausal women (PMW) with early breast cancer (BCa) receiving adjuvant letrozole (LET)
暂无分享,去创建一个
E. Perez | A. Brufsky | R. Coleman | N. Bundred | R. Mena | L. Lacerna | N. Schenk | R. Lambert-Falls | M. Dong